ASND   $129.82  5.85% Market Closed After Close 129.81 -0.01%

Ascendis Pharma A/S
Total Cash 258.70M
totalCashPerShare 4.511
EBITDA -347.19M
Total Debt 672.64M
quickRatio 0.4
currentRatio 0.74
Total Revenue 317.63M
debtToEquity
Revenue/Share 5.595
ROA -0.27923
ROE
grossProfits
freeCashflow -104.13M
operatingCashflow -330.08M
earningsGrowth
revenueGrowth -0.24
grossMargins 0.85556
ebitdaMargins -1.09308
operatingMargins -3.7017899
profitMargins -1.54116
enterpriseValue 7.76B
forwardPE -31.463594
floatShares 56.93M
sharesOutstanding 59.76M
sharesShort 3.23M
sharesShortPriorMonth 3.34M
dateShortInterest
sharesPercentSharesOut 0.05%
heldPercentInsiders 0.01%
heldPercentInstitutions 1.04%
Short Ratio help_outline 4.16%
shortPercentOfFloat 0.08%
impliedSharesOutstanding
bookValue -5.6
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -489.52M
trailingEps -9.38%
forwardEps -4.12%
enterpriseToEbitda -22.36
lastDividendValue
lastDividendDate
currentQuarterEstimate -1.89 3Q 2024
institutionsCount 294
lastUpdated Nov. 6, 2024, 6:29 p.m.